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Bile Acids, But Not Neutral Sterols,
Are Tumor Promoters in the Colon in Man
and in Rodents
by John H. Weisburger,* Bandaru S. Reddy,*
William S. Barnes,* and Ernst L. Wynder*
Analysis of the etiologic factors and relevant mechanisms involved in carcinogenesis leads to a
classification of agents involved in the carcinogenic process as genotoxic or epigenetic. Their mode
of action is distinct, especially with regard to dose-response effects and reversibility. The genotoxic
carcinogens for colon cancer are unknown, but mutagenic components found in fried beef and fish
are under study. Epigenetic agents as promoting factors play a major role in the development of
cancer of the colon. Specific nutritional elements associated with colon cancer risk are high fat
diets, high cholesterol intake, and low fiber intake. The role of micronutrients as modulators and in-
hibitors needs to be explored. Through metabolic studies in diverse populations and in reliable ani-
mal models, it is now clear that dietary fat and cholesterol control the total flow of bile acids in lu-
men and a high-fat, high-cholesterol diet increases the total of bile acids in the gut. Bile acids but
not neutral sterols have promoting effects and are related to colon cancer risk although bile acids
by themselves do not act as complete carcinogens. The effect of dietary fiber such as cereal bran is
to increase stool bulk which dilutes the concentration of bile acids. Reducing the concentration of
bile acids either by lowering dietary fat and cholesterol or by increasing dietary fiber may effec-
tively lower the risk for colon cancer.
Introduction
Various lines of evidence suggest that the major-
ity of human cancers have complex, multifactorial
environmental causes (1-3). In relation to the cancer
question, "causes" are often thought to be ubiqui-
tous chemicals, and, more specifically, those due to
modern technology and industrial development.
Certainly a number of food additives, pesticides, in-
secticides, and industrial chemicals introduced com-
mercially in the last 40 years are carcinogenic in
animal models (4). Historically, it is also true that
chemical exposure due to occupation or to drugs has
caused human cancers (1-3, 5-8). Cancer represents
many diseases, and a detailed analysis of the often
complex factors inherent in the occurrence of each
specific type of cancer is essential to delineate those
elements truly responsible for the occurrence of
each kind of cancer.
In the last two decades it has been established
that chemical contaminants in the environment,
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whether intentional or inadvertent, do not account
for most of the main human cancers in the world.
Worldwide statistics on time trends and the in-
cidence of diverse cancers, as well as the altered
risk for migrants from areas of high to low in-
cidence over several generations and the corre-
sponding analysis of data obtained under controlled
conditions in animal models, outline the multiple
causative factors involved in each of the main
human cancers. Thus, it has been found that in-
dividual and national, traditional lifestyle, as related
to the use of tobacco and broad nutritional factors,
is of great significance (9). It will be useful to
consider current concepts of the mechanisms of
carcinogenesis, and then see how these can be
applied to an evaluation of the role of nutritional
factors in the causation of an important type of
cancer in the Western world-colon cancer.
Mechanisms of Carcinogenesis
Considerable advances have been achieved in
studies on the mechanisms of carcinogenesis. Can-WEISBURGER ETAL.
cer causation and development involves a series of
essential steps. It is likely that an early event in
neoplasia depends on a somatic mutation involving
an alteration of the genetic material (10-12).
We have classified chemical carcinogens into
eight classes that, in turn, belong to two main
groups: genotoxic carcinogens and agents operating
by nongenotoxic or epigenetic pathways such as
promotion (13). In relation to an understanding of
the relevant mechanisms, this classification is
important in dissecting the complex causes of
diverse kinds of cancer and arriving at a delineation
of the role of each agent-genotoxic carcinogen,
cocarcinogen, or promoter-in the overall car-
cinogenic process for each kind of cancer.
Genotoxic Events
A change in the genetic material can arise
through a number of mechanisms: (1) through a di-
rect attack by (a) radiation, (b) chemicals, or (c) vi-
ruses, which may result in the mispairing of bases
during DNA replication, or by viral insertion of new
DNA segments to yield abnormal DNA; (2) through
defective operation of DNA polymerase during
synthesis; (3) through errors introduced by DNA
repair enzymes.
Nongenotoxic or Epigenetic Events
Abnormal DNA obtained by any mechanism is
only the first step in a long sequence of events ter-
minating in a malignant invasive neoplasm. An
important element is the ability of an abnormal cell
population to achieve a selective growth advantage
in the presence of surrounding normal cells. The
process of cell duplication is highly dependent on a
number of endogenous and exogenous controlling
elements operating by epigenetic mechanisms. Two
such elements are promoters and inhibitors of
growth, which either enhance or retard the process.
In addition, during the multiple generation steps,
early tumor cells can undergo phenotypic changes
of expression, perhaps as a result of faulty steps in
differentiation.
As numerous experiments documenting this phe-
nomenon indicate, promoters do not lead to the
production of an invasive cancer in the absence of
an antecedent cell change (12-16). Thus, in exploring
the causes of any specific human cancer, con-
sideration must be given both to the agents leading
to an abnormal genome and any other agents
possibly involved in the growth and development of
the resulting abnormal neoplastic cells and their
further progression to malignancy.
Genotoxic Carcinogens for Cancer
of the Colon
Until recently there were no data as to the geno-
toxic carcinogens responsible for nonoccupational
human cancer in the general public in western
countries, except for those found in tobacco smoke
(2, 16). This is especially so for nutritionally linked
cancers such as colon, breast and prostate.
It was discovered that charcoal broiling of meat
or fish yielded mutagenic activity for Salmonella
typhimurium TA-98 (17, 18). Since mutagenic ac-
tivity is often an indicator of carcinogenic activity,
studies on the effects of mode of cooking of foods
are taking place (19). One mutagenic component
found in fried sardines and in fried beef, 2-amino-3-
methylimidazo-[4,5-d]quinoline, is similar sterically
and structurally to known homocyclic carcinogenic
arylamines, such as 3, 2'-dimethyl-4-aminobiphenyl,
which are colon, mammary gland, and prostate
carcinogens in rodents (19). The main mutagens in
fried meat or fish most probably do not derive only
from the pyrolysis of amino acids or peptides but
also from the formation of heterocyclic compounds
from carbohydrate components and amino acids, as
formed in a model system for browning reactions
involving the reaction of sugars with ammonium
ions (20, 21).
Nongenotoxic or Epigenetic
Agents in Nutritionally Linked
Cancers
Delineating the relevant epigenetic promoting ef-
fects for cancer of the colon is important because
whether or not overt invasive disease is seen
depends a great deal on these epigenetic promoting
factors. Epigenetic agents play a major, perhaps
decisive, role in the development of cancer of the
colon, and incidentally also of the breast, and
prostate. These stem from the intake of appreciable
amounts of dietary fat which are responsible for the
endogenous production of specific nongenotoxic,
epigenetic agents associated with increased risk.
For colon cancer, the specific dietary elements,
relevant through studies in man and in animal
models, are the amount of dietary fat and fiber (22,
23). One of the best arguments for these concepts is
the changing incidence of colon cancer in Japan in
recent years as the Japanese nutritional intake has
become progressively westernized (24). In addition,
in many areas of the world, an association exists
between colon cancer and coronary heart disease,
where the amount of dietary fat and cholesterol
have been shown to relate to risk for heart disease.
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An interesting exception to this rule is Finland,
where the risk for heart disease is high and that of
colon cancer low; we, as well as the IARC, have ob-
tained some evidence that the lower risk of Finnish
people for colon cancer despite a high fat intake is
attributable to their consumption of foods high in
fiber, especially bran fiber (23, 25).
Laboratory research by a number of groups, par-
ticularly by Reddy (23) and by Nigro (26), yields
insight into the mechanism whereby fat and
cholesterol promote colon cancer risk and fiber
inhibits colon carcinogenesis. The main effect of
dietary fat appears to reside in a direct association
between endogenous cholesterol biosynthesis,
which when combined with exogenous cholesterol
intake, in turn, leads to increased bile acid
biosynthesis and excretion through the intestinal
tract (Table 1). Certain bile acids and neutral sterols
were of interest because they induced sarcomas but
not carcinomas at the injection site in experimental
animals (28-30). However, this evidence of oncogenic
effect does not implicate them or their metabolites
in carcinomas in the large bowel. Instead, this
reaction represents an instance of "solid-state" onco-
genesis, yielding tumors in the mesenchymal tissue,
and must be considered quite unrelated to the effect
of neutral sterols and bile acids in colon cancer
causation. Rather, certain bile acids have been
shown to be colon tumor promoters in both germ-
free and conventional rats (Tables 2 and 3). Bile
acids do not act as complete carcinogens, and their
role would seem to be to act as epigenetic agents in
the overall carcinogenic process. (23, 30). At the
same time, the cholesterol metabolites, including
the a-epoxide, or neutral sterols, not only did not by
themselves, or by their metabolites produced by
colonic bacteria, induce tumors in the colon or germ-
free and conventional rats but also had no
promoting activity (30, 31).
The colonic cells during neoplastic transformation
undergo a similar sequence of changes which lead to
uncontrolled proliferative growth in the develop-
ment of colon cancers in humans and rodents
treated with colon carcinogens (32). Further studies
are needed on the mechanisms whereby bile acids
enhance cell proliferation and possibly also affect
the functional differentiation of colonic cells during
their upward migration in a crypt.
The effect of some dietary fibers (Table 4), such
as cereal brans, is to increase intestinal and stool
bulk, thereby reducing the concentration of pro-
moters, effectively lowering the risk for develop-
ment of colon cancer incidence in populations such
as the Mormons and the Finns, who consume fried
meat and other sources of genotoxic carcinogens
and appreciable amounts of fat which lead to
promoters but who also eat sizable amounts of
cereal grains, may thus be explained by stool bulk
acting as a modulator of promotion by reducing bile
acid concentration (Tables 5 and 6).
More research is also needed on modulators and
inhibitors, such as micronutrients, that would
eventually find application in lowering human
disease risk. The role of yellow-green vegetables,
especially from the Brassica family, in apparently
lowering the colon cancer risk remains to be
defined. It is not clear whether the active in-
gredients in such vegetables modify the metabolism
of the genotoxic carcinogens associated with colon
cancer, whether they play a role in bile acid
Table 1. Effect of type and amount of dietary fat on fecal acids in rats.a
Fecal bile acids, mg/kg/dayb c
5% Corn oil 20% Corn oil 5% Lard 20% Lard
control control control control
(8) (8) (8) (8)
Cholic acid 0.68 ± 0.08b' 0.64 ± 0.07' 0.74 ± 0.06' 0.86 ± 0.10'
P-Muricholic acid 0.82 ± 0.05' 0.98 ± 0.08' 0.80 ± 0.07' 0.88 ± 0.11'
3a.9.12a-Trihydroxy-5f3-cholanic acid 0.11 ± 0.02' 0.10 ± 0.01' 0.10 ± 0.01' 0.13 ± 0.01'
Chenodeoxycholic acid 0.12 ± 0.01' 0.15 ± 0.01' 0.13 ± 0.02' 0.16 ± 0.03'
Hyodeoxcholic acid 2.76 ± 0.12' 2.73 ± 0.16' 3.14 ± 0.18' 2.73 ± 0.17'
Ursodeoxycholic acid 0.10 ± 0.2' 0.10 + 0.02' 0.15 + 0.09' 0.08 ± 01'
Deoxycholic acid 2.53 ± 18' 4.80 + 0.232 2.61 + 0.220' 4.54 ± 0.302
Lithocholic acid 0.83 ± 0.11' 1.98 + 0.162 1.00 + 0.10' 2.84 ± 0.132
12-Ketolithocholic acid 0.44 ± 0.03' 0.77 + 0.072 0.51 + 0.18' 0.77 ± 0.022
7-Ketodeoxycholic acid 0.14 + 0.02' 0.08 ± 0.01' 0.16 ± 0.02' 0.06 + 0.01'
Other bile acids 1.93 ± 0.10 2.52 ± 0.25 1.92 ± 0.16 2.51 ± 0.19
Total bile acids 10.45 ± 0.20' 14.86 ± 0.412 11.24 ± 0.49' 14.91 ± 0.622
aWeanling female F344 rats were fed an experimental diet containing either 5% or 20% corn oil or 5% or 20% lard, and indi-
vidual daily fecal samples were collected 14 weeks later for 5 days. Fecal samples from each animal were subjected to bile acid
analysis. From Reddy et al. (23, 27).
bMean ± SEM. Units: mg/day/kg body weight.
cMean ± with a common number superscript between groups in a horizontal row are not significant: p > 0.05.WEISBURGER ETAL.
production or further metabolism, or in the
metabolism of other, as yet unknown, epigenetic
promoting agents 1, 2, 3 (35-37).
Since these elements operate through epigenetic
mechanisms, their action is, by definition, dose- and
time-dependent. Thus, a reduction in effective dose,
by whatever means, would be expected to lead to
rather rapid lowering of risk, and hence of in-
cidence. This applies even to patients with such
diseases, where dietary intervention promises to be
an effective adjuvant therapy. When the post-
menopausal use of estrogen drugs such as premarin
was discontinued, there was a rapid decline in
endometrial cancer, indicating that epigenetic
phenomena are reversible.
If current research does document further that
the mode of cooking, especially frying and broiling,
yields carcinogens for colon cancer, means are
available to lower the formation of such agents.
Furthermore, and importantly, if colon cancer risk
is indeed associated with the level of dietary fat and
inversely with the amount of cereal fiber, with the
Table 2. Colon tumor incidence in germfree rats treated with intrarectal MNNG and/or bile acids or neutral sterolsa
Tumors/rat
No. of Animals
Seriesb Groupc rats with tumors Total Adenoma Adenocarcinoma
I CA 10 0 0 0 0
CDC 10 0 0 0 0
MNNG 22 27 0.27 0.13 0.14
MNNG + CA 24 50 0.63 0.34 0.29
MNNG + CDC 24 54 1.08 0.79 0.29
II LC 12 0 0 0 0
MNNG 24 38 0.67 0.42 0.25
MNNG + LC 24 79 1.42 1.00 0.42
III Cholesterol 15 0 0 0 0
Epoxide 21 0 0 0 0
Triol 15 0 0 0 0
MNNG 24 46 0.63 0.50 0.13
MNNG + 24 46 0.67 0.42 0.25
cholesterol
MNNG + Epoxide 24 58 0.71 0.54 0.17
MNNG + Triol 24 46 0.54 0.46 0.08
aData from Reddy et al. (23).
bIn Series I, the CA or CDC group received intrarectally 20 mg of sodium salt of respective bile acids 3 times weekly for 48
weeks; MNNG group received intrarectally 2 mg of MNNG twice a week for 2 weeks, followed by vehicle for 46 weeks; MNNG +
CA or MNNG + CDC group received intrarectally MNNG for 2 weeks and bile acids thereafter for 46 weeks. In Series II and III,
the MNNG group received 2.5 mg MNNG t-wice a week for 2 weeks and the vehicle thereafter for 46 weeks. The experimental
protocol for the bile acids and cholesterol metabolite administration is the same as described for Series I.
CCA, cholic acid; CDC. chenodeoxycholic acid; LC. lithocholic acid) Epoxide, cholesterol-a-epoxide) Triol. cholestane-3, 5, 6-triol)
MNNG, N-methyl-N'-nitro-N-nitrosoguanidine.
Table 3. Colon tumor incidence in conventional rats treated with intrarectal MNNG and/or bile acids or neutral sterolsa
No. of Animals Tumors/rat
Seriesb Groupb rats with tumors Total Adenoma Adenocarcinoma
CA 12 0 0 0 0
CDC 12 0 0 0 0
MNNG 30 37 0.55 0.23 0.32
MNNG + CA 30 67 0.87 0.24 0.63
MNNG + CDC 30 70 1.23 0.27 0.96
II LC 12 0 0 0 0
MNNG 24 54 1.00 0.75 0.25
MNNG + LC 24 83 1.83 1.50 0.33
III Cholesterol 15 0 0 0 0
Epoxide 21 0 0 0 0
Triol 15 0 0 0 0
MNNG 24 71 1.29 0.96 0.33
MNNG + cholesterol 24 71 1.04 0.67 0.38
MNNG + Epoxide 24 58 1.08 0.71 0.38
MNNG + Triol 24 58 0.96 0.75 0.21
aData from Reddy et al. (27).
bThe experimental protocols and abbreviations are the same as described for Table 2.
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Table 4. Intestinal tumor incidence in rats fed diets containing pectin, alfalfa or wheat bran and treated with AOM.a
Total number of
Animals with colon tumors per No. of
colon tumors Colon tumors group by tumor classification animals
Dietb with
Per tumor- Carcinoma Adeno- duodenal
No. % Per rat bearing rat Adenoma in situ carcinoma tumors
Control (30) 17 57 0.8 1.5 14 5 6 2
Pectin (30) 3 10* 0.1 0.1 0 0 3 0
Alfalfa (30) 16 53 0.7 1.3 8 3 10 6
Wheat bran (30) 10 33** 0.4 1.2 3 1 8 2
aWeanling female F344 rats were fed semipurified diets containing 0 or 15% pectin, alfalfa, or wheat bran. At 7 weeks of age, all
animals except vehicle-treated controls received azoxymethane (AOM) SC at a dose rate 8 mg/kg body weight/week for 10 weeks.
All animals were necropsied 30 weeks later. Data from Watanabe et al. (33).
bEffective number of animals in each group is shown in parentheses.
*Significantly different from the groups fed the control diet, alfalfa diet, or wheat bran diet by x2 test (p<0.05 or better).
**Significantly different from the groups fed the control diet or alfalfa diet by x2 test (p<0.05 or better).
Table 5. Fecal bile acids of healthy male subjects from Kuopio (Finland) and New York metropolitan area.a
Average as mg/gb Average as mg/dayb
Kuopio New York Kuopio New York
Bile acids (15) (20) (15) (20)
Cholic acid 0.20 ± 0.06 0.24 ± 0.04 12 ± 2.9 6 + 1.4
Chenodeoxycholic acid 0.13 ± 0.03 0.23 ± 0.03 8 ± 1.3 5 ± 1.1
Deoxycholic acid 1.72 ± 0.16* 3.74 ± 0.26 104 ± 12 88 ± 5.1
Lithocholic acid 1.40 ± 0.16* 3.27 ± 0.15 84 ± 5 77 ± 4.5
Ursodeoxycholic acid 0.08 ± 0.02* 0.13 ± 0.01 5 ± 1.1 3 ± 0.3
3a,7p,12a-Trihydroxy-5p-cholanic acid 0.04 ± 0.01* 0.12 ± 0.01 2 ± 0.8 3 ± 0.3
12-Ketolithocholic acid 0.06 ± 0.02* 0.13 ± 0.01 4 ± 1.0 3 ± 0.2
Other bile acids 0.93 ± 0.08* 3.8 ± 0.26 56 ± 5.Ot 89 ± 6.0
Total 4.59 ± 0.42 11.7 ± 0.54 277 ± 22 275 ± 14
aData from Reddy et al. (34).
bAverages ± SEM.
*Significantly different from New York, p<0.05 or better.
Table 6. Epidemiology of large bowel cancer.a
Fecal constituents
Stool Promoters
Dietary factorsb bulk, (bile acids)
Fat Beef Fiber g/day mg/g mg/day
High risk
United States + + + +++ + 22 11.7 275
Low risk
Finland + + + + + + + + 60 4.6 277
Japan + +c + 23 4.8 110
aData from Reddy et al. (34).
bThe following score has been assigned based on nutritional data available: + + +, high dietary intake; + +, moderate dietary
intake; + , low dietary intake.
cFiber intake in Japan is slightly higher than United States.
Table 7. Comparison of high and low risk dietary factors for cancer in the colon.
Lower risk Higher risk
Organ Population Dietary factors Population Dietary factors
Colon Japan Low fat diet USA, Western Europe, High fat and cholesterol,
New Zealand, low fiber, diets;
Australia, Scandinavia fried food
Colon Mormons Higher fiber USA in general High fat and cholesterol,
low fiber
Colon 7th Day Low or no fried food, USA in general High fat and cholesterol,
Adventists higher fiber low fiber
Colon Finland Higher fiber, lower USA in general, High fat and cholesterol,
fried food Denmark low fiber
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Table 8. Current concepts on colon cancer causation and development.
Risk factors
Diets high in fat, cholesterol, fried foods
Diets low in fiber, yellow and green vegetables
Established mechanisms
High fat - High cholesterol biosynthesis - High gut bile acid levels
High dietary cholestrol t
Low fiber - High concentration of gut bile acids
(low dilution through lack of bulk)
High bile acid concentration - Promoting effect in colon carcinogenesis
Mechanisms under study
Fried food - Mutagens - Colon carcinogens?
Role of micronutrients (vitamins and minerals) and different types of fiber in production and metabolism of carcinogens, bile
acids, promoters?
Mechanisms of promotion?
aData of Weisburger et al. (38).
concentration of bile acids as the crucial element in
the promoting process, this evidence can be the
basis for suggesting relatively minor alterations in
dietary habits involving mainly a lower fat intake
and a higher fiber consumption as tools to lower dis-
ease risk (Table 7).
Along these lines, research on optimal levels of
vitamins, minerals and other micronutrients as well
as antioxidants and certain indoles, in the current
diet would provide a broad basis for chemopreven-
tion. Over the last several years, research has
provided new perspectives on the causes and
modifiers of the main premature killing diseases.
Data in the current paper specifically record ex-
perimentation designed to yield understanding of
underlying mechanisms as a sound reliable basis for
prevention of an important kind of human cancer,
colon cancer and for the long-term goals of disease
prevention (Table 8).
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